Epoxy resin-based cathodic electrodeposition paint containing
hydrophobic monoepoxide-amine adducts
    1.
    发明授权
    Epoxy resin-based cathodic electrodeposition paint containing hydrophobic monoepoxide-amine adducts 失效
    含有疏水单环氧化物 - 胺加合物的环氧树脂基阴极电沉积涂料

    公开(公告)号:US5418263A

    公开(公告)日:1995-05-23

    申请号:US229612

    申请日:1994-04-19

    CPC classification number: C09D5/4457

    Abstract: A cathodic electrodeposition paint containing as a binder resin an amine-epoxy resin adduct and a blocked polyisocyanate crosslinker is disclosed. The binder resin and the crosslinker are emulsified in an aqueous medium containing a neutralizing agent with the aid of amine adduct of a monoepoxide compound having a hydrophobic group or block. Not only the amine-monoepoxide adduct functions as a surfactant but also it is deposited electrically and then cured with the crosslinker integrally with the binder resin.

    Abstract translation: 公开了一种含有胺 - 环氧树脂加合物和封端多异氰酸酯交联剂作为粘合剂树脂的阴极电沉积涂料。 借助于具有疏水基团或嵌段的单环氧化物的胺加合物,将粘合剂树脂和交联剂在含有中和剂的水性介质中乳化。 胺单环氧化物加合物不仅起表面活性剂的作用,而且还被电沉积,然后与交联剂与粘合剂树脂一体固化。

    N-glucoside compounds having an inhibitory activity against sodium-dependent glucose transporter
    2.
    发明授权
    N-glucoside compounds having an inhibitory activity against sodium-dependent glucose transporter 失效
    对钠依赖性葡萄糖转运蛋白具有抑制活性的N-葡萄糖苷化合物

    公开(公告)号:US07521430B2

    公开(公告)日:2009-04-21

    申请号:US10566585

    申请日:2004-07-30

    CPC classification number: C07H15/203 C07H5/04 C07H17/02

    Abstract: A compound of the formula: wherein Ring A and Ring B are (1) Ring A is an optionally substituted unsaturated monocyclic heterocyclic ring, and Ring B is an optionally substituted unsaturated monocyclic heterocyclic ring, an optionally substituted unsaturated fused heterobicyclic ring, or an optionally substituted benzene ring, (2) Ring A is an optionally substituted benzene ring, and Ring B is an optionally substituted unsaturated monocyclic heterocyclic ring, an optionally substituted unsaturated fused heterobicyclic ring, or an optionally substituted benzene ring, or (3) Ring A is an optionally substituted unsaturated fused heterobicyclic ring, wherein —NR— group and —CH2— group are both on the same ring of the unsaturated fused heterobicyclic ring, and Ring B is an optionally substituted monocyclic unsaturated heterocyclic ring, an optionally substituted unsaturated fused heterobicyclic ring, or an optionally substituted benzene ring; and R is a hydrogen atom, a lower alkyl group, a lower alkanoyl group or a lower alkoxycarbonyl group, or a pharmaceutically acceptable salt thereof, or a prodrug thereof.

    Abstract translation: 下式的化合物:其中环A和环B是(1)环A是任选取代的不饱和单环杂环,环B是任选取代的不饱和单环杂环,任选取代的不饱和稠合杂双环或任选地 取代的苯环,(2)环A是任选取代的苯环,环B是任选取代的不饱和单环杂环,任选取代的不饱和稠合杂双环或任选取代的苯环,或(3)环A是 任选取代的不饱和稠合杂双环,其中-NR-基和-CH2-基都在不饱和稠合杂双环的相同环上,环B是任选取代的单环不饱和杂环,任选取代的不饱和稠合杂双环 ,或任选取代的苯环; 或其前体药物,R为氢原子,低级烷基,低级烷酰基或低级烷氧基羰基,或其药学上可接受的盐。

    SULFONAMIDE COMPOUNDS HAVING TRPM8 ANTAGONISTIC ACTIVITY
    4.
    发明申请
    SULFONAMIDE COMPOUNDS HAVING TRPM8 ANTAGONISTIC ACTIVITY 有权
    具有TRPM8拮抗活性的磺酰胺化合物

    公开(公告)号:US20140005393A1

    公开(公告)日:2014-01-02

    申请号:US14004911

    申请日:2012-03-15

    Abstract: Sulfonamide compounds having TRPM8 antagonistic activity are provided. A sulfonamide compound of formula (I) or a pharmaceutically acceptable salt thereof, or a prodrug thereof: (I) wherein Ring A is bicyclic aromatic heterocycle comprised of (a) pyridine is condensed with benzene; or (b) pyridine is condensed with monocyclic aromatic heterocycle, and Ring A binds to a sulfonylamino moiety on a carbon atom adjacent to a nitrogen atom of the pyridine ring constituting Ring A, Ring B is (a) monocyclic or bicyclic aromatic hydrocarbon; (b) monocyclic or bicyclic alicyclic hydrocarbon; (c) monocyclic or bicyclic aromatic heterocycle; or (d) monocyclic or bicyclic non-aromatic heterocycle, Ring C is (a) benzene; or (b) monocyclic aromatic heterocycle, and other symbols are the same as defined in the specification.

    Abstract translation: 提供了具有TRPM8拮抗活性的磺酰胺化合物。 式(I)的磺酰胺化合物或其药学上可接受的盐或其前药:(I)其中环A是由(a)吡啶组成的双环芳族杂环与苯稠合; 或(b)吡啶与单环芳族杂环稠合,环A与构成环A的吡啶环的氮原子相邻的碳原子上的磺酰基氨基部分结合,环B为(a)单环或双环芳烃; (b)单环或双环脂环烃; (c)单环或双环芳族杂环; 或(d)单环或双环非芳族杂环,环C为(a)苯; 或(b)单环芳族杂环,以及其他符号与说明书中所定义的相同。

    AROMATIC NITROGEN-CONTAINING 6-MEMBERED RING COMPOUNDS AND THEIR USE
    5.
    发明申请
    AROMATIC NITROGEN-CONTAINING 6-MEMBERED RING COMPOUNDS AND THEIR USE 审中-公开
    含有硝酸的六元环化合物及其用途

    公开(公告)号:US20110166135A1

    公开(公告)日:2011-07-07

    申请号:US13062841

    申请日:2009-09-09

    Abstract: The present invention provides aromatic nitrogen-containing 6-membered ring compounds having excellent PDE10 inhibitory activity. The present invention relates to an aromatic nitrogen-containing 6-membered ring compound represented by the following formula [I0] or a pharmaceutically acceptable salt thereof, a method for preparing the same, and use of said compounds for PDE10 inhibitors, and a pharmaceutical composition comprising said compounds as an active ingredient: Formula [I0] wherein: X1, X2 and X3 each independently are N or CH, and at least two of X1, X2 and X3 are N; A is *—CH═CH—, *—C(Alk)=CH—, *—CH2—CH2— or *—O—CH2— (* is a bond with R1); Alk is a lower alkyl group; Ring B is an optionally substituted nitrogen-containing aliphatic heterocyclic group; R1 is an optionally substituted nitrogen-containing heterocyclic group, a nitrogen-containing heterocyclic moiety of which is a moiety selected from the group consisting of quinoxalinyl, quinolyl, isoquinolyl, quinazolinyl, pyrazinyl, pyrimidinyl and a moiety thereof fused with a 5 to 6-membered aliphatic ring thereto; Y0 is a group selected from the group consisting of the following (1) to (5): (1) an optionally substituted phenyl or an optionally substituted aromatic monocyclic 5 to 6-membered heterocyclic group; (2) an optionally substituted aminocarbonyl; (3) an optionally substituted amino lower alkyl; (4) —O—R2 wherein R2 is hydrogen, an optionally substituted lower alkyl, lower cycloalkyl, aliphatic monocyclic 5 to 6-membered heterocyclic group, or Formula [AA]; (5) mono- or di-substituted amino; provided that, when Y0 is mono- or di-substituted amino, the nitrogen-containing heterocyclic moiety of R1 is not quinoxalinyl or quinolyl.

    Abstract translation: 本发明提供具有优异的PDE10抑制活性的芳香族含氮6元环化合物。 本发明涉及由下式[I0]表示的含芳族含氮的6元环化合物或其药学上可接受的盐,其制备方法以及所述化合物用于PDE10抑制剂的用途和药物组合物 包括所述化合物作为活性成分:式[I0]其中:X1,X2和X3各自独立地为N或CH,X1,X2和X3中的至少两个为N; A是* -CH = CH-,* -C(Alk)= CH-,* -CH2-CH2-或* -O-CH2-(*是与R1的键); Alk是低级烷基; 环B是任选取代的含氮脂族杂环基; R1是任选取代的含氮杂环基团,其含氮杂环部分是选自喹喔啉基,喹啉基,异喹啉基,喹唑啉基,吡嗪基,嘧啶基及其部分与5至6位稠合的部分, 元环脂族环; Y0是选自下列(1)至(5)的基团:(1)任选取代的苯基或任选取代的芳族单环5至6元杂环基; (2)任选取代的氨基羰基; (3)任选取代的氨基低级烷基; (4)-O-R2,其中R2是氢,任选取代的低级烷基,低级环烷基,脂族单环5至6元杂环基或式[AA]; (5)单取代或二取代氨基; 条件是当Y 0是单取代或二取代的氨基时,R 1的含氮杂环部分不是喹喔啉基或喹啉基。

    Drying machine
    8.
    发明授权
    Drying machine 失效
    烘干机

    公开(公告)号:US5367787A

    公开(公告)日:1994-11-29

    申请号:US102307

    申请日:1993-08-05

    Abstract: A drying machine has a drying chamber for drying an article cleaned with an inflammable solvent as a detergent. A hot air supply channel communicates with the drying chamber and a heater is mounted in the hot air supply channel. A hot air evacuation channel communicates with the drying chamber and a hot air transfer device is mounted at a voluntary portion of the hot air supply channel and the hot air evacuation channel. A control device is provided for driving control of the heater. A first temperature sensor is mounted on the downstream side of the heater in the hot air supply channel and a second temperature sensor is mounted at a position shifted to the drying chamber in the hot air evacuation channel. The control device controls the heater so that the difference in the temperature detected by the first temperature sensor and the temperature detected by the second temperature sensor is kept within a safe temperature range.

    Abstract translation: 干燥机具有干燥室,用于干燥用易燃溶剂清洗的物品作为洗涤剂。 热风供应通道与干燥室连通,并且加热器安装在热空气供应通道中。 热空气排出通道与干燥室连通,热空气传送装置安装在热空气供应通道和热空气排出通道的自愿部分。 提供控制装置用于驱动加热器的控制。 第一温度传感器安装在热空气供应通道中的加热器的下游侧,并且第二温度传感器安装在位于热空气排出通道中的干燥室的位置。 控制装置控制加热器,使得由第一温度传感器检测到的温度差和由第二温度传感器检测到的温度保持在安全的温度范围内。

    Novel compounds
    10.
    发明申请
    Novel compounds 失效
    新型化合物

    公开(公告)号:US20070060545A1

    公开(公告)日:2007-03-15

    申请号:US10566585

    申请日:2004-07-30

    CPC classification number: C07H15/203 C07H5/04 C07H17/02

    Abstract: A compound of the formula: wherein Ring A and Ring B are (1) Ring A is an optionally substituted unsaturated monocyclic heterocyclic ring, and Ring B is an optionally substituted unsaturated monocyclic heterocyclic ring, an optionally substituted unsaturated fused heterobicyclic ring, or an optionally substituted benzene ring, (2) Ring A is an optionally substituted benzene ring, and Ring B is an optionally substituted unsaturated monocyclic heterocyclic ring, an optionally substituted unsaturated fused heterobicyclic ring, or an optionally substituted benzene ring, or (3) Ring A is an optionally substituted unsaturated fused heterobicyclic ring, wherein —NR— group and —CH2— group are both on the same ring of the unsaturated fused heterobicyclic ring, and Ring B is an optionally substituted monocyclic unsaturated heterocyclic ring, an optionally substituted unsaturated fused heterobicyclic ring, or an optionally substituted benzene ring; and R is a hydrogen atom, a lower alkyl group, a lower alkanoyl group or a lower alkoxycarbonyl group, or a pharmaceutically acceptable salt thereof, or a prodrug thereof.

    Abstract translation: 下式的化合物:其中环A和环B是(1)环A是任选取代的不饱和单环杂环,环B是任选取代的不饱和单环杂环,任选取代的不饱和稠合杂双环或任选取代的不饱和单环杂环 取代的苯环,(2)环A是任选取代的苯环,环B是任选取代的不饱和单环杂环,任选取代的不饱和稠合杂双环或任选取代的苯环,或(3)环A是 任选取代的不饱和稠合杂双环,其中-NR-基团和-CH 2 - 基团都在不饱和稠合杂双环环的相同环上,环B是任选取代的单环不饱和杂环 ,任选取代的不饱和稠合杂双环,或任选取代的苯环; 或其前体药物,R为氢原子,低级烷基,低级烷酰基或低级烷氧基羰基,或其药学上可接受的盐。

Patent Agency Ranking